Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes
- 21 February 1997
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 60 (13-14), 1047-1052
- https://doi.org/10.1016/s0024-3205(97)00046-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Preclinical and Phase 1 clinical characterization of CI-979/ RU35926, a novel muscarinic agonist for the treatment of Alzheimer's diseaseLife Sciences, 1995
- Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's diseaseLife Sciences, 1995
- A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study GroupPublished by American Medical Association (AMA) ,1994
- New functionally selective muscarinic agonistsLife Sciences, 1993
- The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivoLife Sciences, 1993
- Chapter 34 The cholinergic system in Alzheimer diseasePublished by Elsevier ,1990
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEThe Lancet, 1976